Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease - PubMed (original) (raw)
Case Reports
Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease
T Fukuda et al. Acta Pathol Jpn. 1993 Oct.
Abstract
Three cases of Lewy body disease were investigated in order to compare the morphological and immunohistochemical characteristics of the neuronal inclusions in the cerebral cortex (CC) and brain-stem (BS). Ultrastructurally, the CC contained intermediate-sized filaments with variable amounts of granular material and other organelles, whereas the BS consisted of an electron-dense core and an outer area with radially oriented filaments. The cerebral cortex was immuno-reactive with antibodies against tyrosine hydroxylase (TH) and tau protein, and differed from BS. In addition, although the CC were antigenically similar to BS in their neurofilament (70, 160 and 200 kDa) and ubiquitin contents, the localization of neurofilament immunoreactivity differed between them, being confined positively to the core of CC, but to the periphery of the BS. Although Lewy bodies (LB) in idiopathic Parkinson's disease are morphologically similar to BS, they have been reported to differ in their immunoreactivity with antibodies against tau. It has been reported that CC differ from LB with regard to immunoreactivity with antibodies against TH and tropomyosin. It is inferred that these inclusions (CC, BS and LB) differ in morphogenesis.
Similar articles
- Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies.
Tiller-Borcich JK, Forno LS. Tiller-Borcich JK, et al. J Neuropathol Exp Neurol. 1988 Sep;47(5):526-35. doi: 10.1097/00005072-198809000-00004. J Neuropathol Exp Neurol. 1988. PMID: 2845001 - Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease.
Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ. Lennox G, et al. J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):67-71. doi: 10.1136/jnnp.52.1.67. J Neurol Neurosurg Psychiatry. 1989. PMID: 2540286 Free PMC article. - Presenile dementia with Alzheimer-, Pick- and Lewy-body changes.
Kosaka K, Oyanagi S, Matsushita M, Hori A. Kosaka K, et al. Acta Neuropathol. 1976 Nov 15;36(3):221-33. doi: 10.1007/BF00685366. Acta Neuropathol. 1976. PMID: 188300 - Dementia and Parkinson's disease--pathological and neurochemical considerations.
Quinn NP, Rossor MN, Marsden CD. Quinn NP, et al. Br Med Bull. 1986 Jan;42(1):86-90. doi: 10.1093/oxfordjournals.bmb.a072104. Br Med Bull. 1986. PMID: 3006860 Review. No abstract available. - Lewy-body formation is an aggresome-related process: a hypothesis.
Olanow CW, Perl DP, DeMartino GN, McNaught KS. Olanow CW, et al. Lancet Neurol. 2004 Aug;3(8):496-503. doi: 10.1016/S1474-4422(04)00827-0. Lancet Neurol. 2004. PMID: 15261611 Review.
Cited by
- Familial encephalopathy with neuroserpin inclusion bodies.
Davis RL, Holohan PD, Shrimpton AE, Tatum AH, Daucher J, Collins GH, Todd R, Bradshaw C, Kent P, Feiglin D, Rosenbaum A, Yerby MS, Shaw CM, Lacbawan F, Lawrence DA. Davis RL, et al. Am J Pathol. 1999 Dec;155(6):1901-13. doi: 10.1016/S0002-9440(10)65510-1. Am J Pathol. 1999. PMID: 10595921 Free PMC article. - The Lewy body in Parkinson's disease and related neurodegenerative disorders.
Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H. Wakabayashi K, et al. Mol Neurobiol. 2013 Apr;47(2):495-508. doi: 10.1007/s12035-012-8280-y. Epub 2012 May 24. Mol Neurobiol. 2013. PMID: 22622968 Review. - Lewy bodies.
Shults CW. Shults CW. Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1661-8. doi: 10.1073/pnas.0509567103. Epub 2006 Jan 31. Proc Natl Acad Sci U S A. 2006. PMID: 16449387 Free PMC article. - α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox.
Simon C, Soga T, Okano HJ, Parhar I. Simon C, et al. Cell Biosci. 2021 Nov 19;11(1):196. doi: 10.1186/s13578-021-00709-y. Cell Biosci. 2021. PMID: 34798911 Free PMC article. Review. - CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer's disease as an indicator of tau phosphorylation.
Shim KH, Kang MJ, Suh JW, Pyun JM, Ryoo N, Park YH, Youn YC, Jang JW, Jeong JH, Park KW, Choi SH, Suk K, Lee HW, Ko PW, Lee CN, Lim TS, An SSA, Kim S; Alzheimer’s Disease All Markers (ADAM) Research group. Shim KH, et al. Alzheimers Res Ther. 2020 Jul 13;12(1):83. doi: 10.1186/s13195-020-00648-9. Alzheimers Res Ther. 2020. PMID: 32660565 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical